Lennol, Matthew PaulSánchez-Domínguez, IreneCuchillo-Ibañez, InmaculadaCamporesi, ElenaBrinkmalm, GunnarAlcolea, DanielFortea, JuanLleó Bisa, AlbertoSoria, GuadalupeAguado Tomàs, FernandoZetterberg, HenrikBlennow, KajSáez-Valero, Javier2022-11-142022-11-142022-11-021758-9193https://hdl.handle.net/2445/190785Objective: The purpose of this study was to examine the levels of cerebrospinal fluid (CSF) apolipoprotein E (apoE) species in Alzheimer's disease (AD) patients. Methods: We analyzed two CSF cohorts of AD and control individuals expressing different APOE genotypes. Moreover, CSF samples from the TgF344-AD rat model were included. Samples were run in native- and SDS-PAGE under reducing or non-reducing conditions (with or without β-mercaptoethanol). Immunoprecipitation combined with mass spectrometry or western blotting analyses served to assess the identity of apoE complexes. Results: In TgF344-AD rats expressing a unique apoE variant resembling human apoE4, a ~35-kDa apoE monomer was identified, increasing at 16.5 months compared with wild-types. In humans, apoE isoforms form disulfide-linked dimers in CSF, except apoE4, which lacks a cysteine residue. Thus, controls showed a decrease in the apoE dimer/monomer quotient in the APOE ε3/ε4 group compared with ε3/ε3 by native electrophoresis. A major contribution of dimers was found in APOE ε3/ε4 AD cases, and, unexpectedly, dimers were also found in ε4/ε4 AD cases. Under reducing conditions, two apoE monomeric glycoforms at 36 kDa and at 34 kDa were found in all human samples. In AD patients, the amount of the 34-kDa species increased, while the 36-kDa/34-kDa quotient was lower compared with controls. Interestingly, under reducing conditions, a ~100-kDa apoE complex, the identity of which was confirmed by mass spectrometry, also appeared in human AD individuals across all APOE genotypes, suggesting the occurrence of aberrantly resistant apoE aggregates. A second independent cohort of CSF samples validated these results. Conclusion: These results indicate that despite the increase in total apoE content the apoE protein is altered in AD CSF, suggesting that function may be compromised.19 p.application/pdfengcc-by (c) Lennol, Matthew Paul et al., 2022https://creativecommons.org/licenses/by/4.0/Malaltia d'AlzheimerLíquid cefalorraquidiAlzheimer's diseaseCerebrospinal fluidinfo:eu-repo/semantics/article7265352022-11-14info:eu-repo/semantics/openAccess